According to FutureWise analysis the market for liposome drug delivery in 2023 is US$ 5.11 billion, and is expected to reach US$ 9.97 billion by 2031 at a CAGR of 8.72%.
Liposomes are new drug delivery systems (NDDS) consisting of bilayers that form naturally when phospholipids are dispersed in water. Microscopic vesicles with aqueous volumes are completely enclosed by membranes composed of lipid bilayers. The liposome drug delivery market is capitalizing on this opportunity by investing in nanomaterials such as nanospheres, liposomes, and nanoparticles that have proven antiviral properties. With an increase in vivo and in vitro drug activities, liposomes are increasingly being used in clinical practice. In the liposome drug delivery market, companies are increasingly focused on the development of nanosystems for the delivery of antiviral drugs across cellular and intracellular barriers. Therefore, liposomes have promising potential in ongoing research studies being conducted by healthcare companies for the treatment of Coronavirus.
For pharmaceutical companies, new strategies for surface modification of liposomes are creating incremental opportunities. Several studies have demonstrated that liposome delivery is a useful tool for the vehicle action and delivery of lipophilic, hydrophilic, and amphiphilic compounds. There are however limitations faced by companies in the liposome drug delivery market because of high toxicity and resistance in high doses. Due to this, companies are moving away from simple conventional vesicles and into second-generation liposomes by adapting their lipid composition and surface with different ligands. In recent years, PEGylated liposomes have gained popularity due to their capacity to load more drugs. A novel drug encapsulated within liposomes such as the CPX-1 has been shown to improve disease control for patients suffering from colorectal cancer. Therefore, the revenue of the cancer therapy application segment is expected to grow aggressively over the forecast period.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Liposome Drug Delivery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Liposome Drug Delivery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.